"In vitro and in vivo murine model studies have demonstrated that without measurable toxicity, MYMD-1: Regulates Th1 and the release of TNF-a in a dose dependent manner Ameliorates autoimmune thyroiditis Prevents and reverses multiple sclerosis Improves vital health signs Reverses aging, as measured by key markers for cellular aging and by murine longevity studies."
Jonnie Williams has applied for numerous US and World patents including the latest published 2020-02-27, Entitled "Pharmaceutical Salts of Isomyosmine And Pharmaceutical Compositions Containing Same" which is a mind blower. Check Google Patents for US20200061043A1.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.